Cargando…
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
SUMMARY: We studied new users of oral bisphosphonates and found that less than half persisted with therapy for 2 years, and interruptions in use were common. During a median observation period of 4.7 years, 10% of patients filled only a single prescription, 37% switched therapies and median cumulati...
Autores principales: | Burden, A. M., Paterson, J. M., Solomon, D. H., Mamdani, M., Juurlink, D. N., Cadarette, S. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277689/ https://www.ncbi.nlm.nih.gov/pubmed/21604008 http://dx.doi.org/10.1007/s00198-011-1645-7 |
Ejemplares similares
-
Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018) -
Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018) -
Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage
por: Cadarette, S. M., et al.
Publicado: (2011) -
Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study
por: Pasricha, Sachin V., et al.
Publicado: (2018) -
Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)